NABP Works With Member Boards, FDA to Implement New Compounding Law for the Protection of Public Health
On November 27, 2013, the Drug Quality and Security Act (Act) was signed into law. This law removes the unconstitutional provisions from Section 503A and adds a new Section 503B to the Federal Food, Drug, & Cosmetic Act. The law also provides for the Food and Drug Administration (FDA) to consult with a Pharmacy Compounding […]
Read More ›NABP’s VAWD Program Strengthened, Not Preempted, by New Federal Law
The Drug Supply Chain Security Act (Act), Title II of the Drug Quality and Security Act, was recently signed into law and contains provisions related to the integrity of the drug distribution supply chain. State boards of pharmacy have received correspondence from attorneys indicating that the Act preempts states from recognizing or requiring NABP’s Verified-Accredited […]
Read More ›NABP Model Act Amended to Address Shared Service Concept, Medication Reuse Programs, and Internet Pharmacy Safety
The National Association of Boards of Pharmacy® (NABP®) recently amended the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) in its effort to assist the boards of pharmacy as they work to protect the public health. The Model Act was revised to replace technology-specific language with […]
Read More ›NABP Shares Online Pharmacy Safety Information at International Pharmaceutical Federation World Congress
At the 2013 International Pharmaceutical Federation (FIP) World Congress hosted in Dublin, Ireland, NABP presented information on online pharmacy safety and rogue online drug sellers to delegates at a session dedicated to online health. NABP shared its finding with delegates that almost 97% of more than 10,000 Internet Web sites selling drug products and reviewed […]
Read More ›NABP Delivers Testimony at House Subcommittee Hearing on Reforming Compounding Regulations
A United States House of Representatives subcommittee held a hearing (PDF) July 16, 2013, to examine various bills aimed to implement new frameworks for the regulation of compounding. The Committee on Energy and Commerce, Subcommittee on Health, convened to hear expert testimony from US Food and Drug Administration (FDA) and other experts in health care […]
Read More ›NABP Testifies at US House Subcommittee Hearing Regarding Support for Federal Legislation to Distinguish Between Compounding and Manufacturing
NABP expressed its support for federal legislation that would distinguish between compounding and manufacturing, in testimony (PDF) presented at a United States House subcommittee hearing on May 23, 2013. The hearing, “Examining Drug Compounding” was held to provide US Committee on Energy and Commerce Health Subcommittee members an opportunity to hear testimony from Food and […]
Read More ›NABP’s .PHARMACY Proposal Passes Initial ICANN Evaluation
Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy® (NABP®) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation. NABP intends to launch the .PHARMACY gTLD by the end of 2013, and […]
Read More ›NABP Supports Federal Legislation Creating New Category of Manufacturer Under FDA Oversight, While Maintaining Board of Pharmacy Authority Over Compounding Pharmacies
In testimony presented at a United States Senate Committee Hearing, NABP expressed its support of draft legislation that would create a new category of manufacturer to include entities that engage in large-scale production of sterile non-patient-specific drugs for distribution. The Senate Health, Education, Labor, and Pensions (HELP) committee’s proposed legislation distinguishes between pharmacies engaged in […]
Read More ›NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health
To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program. Revisions to the criteria will allow virtual manufacturers and virtual wholesale distributors – a growing segment of the pharmaceutical wholesale industry – […]
Read More ›Illegal Online Sellers Fuel Global Spread of Fake and Substandard Medications, International Collaboration Key in Response, Reports NABP
The National Association of Boards of Pharmacy® (NABP®) today issued a report emphasizing that the global distribution of counterfeit and substandard medications, fueled by illegal online sellers, demands an international response. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: April 2013, NABP has partnered with regulatory authorities, […]
Read More ›